revenue growth

India’s Torrent Pharma misses third-quarter profit forecast as insulin plant closes

by
India's Torrent Pharma misses third-quarter profit forecast as insulin plant closes

2025-01-24 17:16:00 : (Reuters) – India’s Torrent Pharmaceuticals reported lower-than-expected third-quarter profit on Friday as it plans to close its insulin production facility. The company, best known for its calcium supplement Shelcal 500, saw consolidated net profit rise nearly 14% to 5.03 billion rupees ($58.3 million) in the quarter ended December 31, 2019, below analysts’ … Read more

Dr. Reddy’s to focus on complex products as growth driver to offset Revlimid revenue loss

by
The company’s Q3FY25 growth was largely driven by revenues from the NRT portfolio, as well as revenues from the India business and emerging markets.

2025-01-23 22:13:00 : Dr. Reddy’s is focused on a range of complex drugs, including GLP-1 (such as semaglutide), as well as biosimilars and consumer care, to offset the release of its blockbuster Revlimid (Revlimid) next year, an executive said. ) loss of exclusivity. Dr. Reddy CEO Erez Israel said the pharma giant has additional growth … Read more